This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mashiba T et al. (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23 (Suppl): 36–42
Komatsubara S et al. (2004) Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res 19: 999–1005
Komatsubara S et al. (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18: 512–520
Burr DB et al. (2003) Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 33: 960–969
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has received research support and consultation fees from the following companies: Amgen, Bayer, Chugai, Eli Lilly, GlaxoSmithKline, Gry-Pharma, Merck Sharpe & Dohme, Novartis, Nycomed, Organon, OttoBock, Pfizer, Procter & Gamble, Roche, Schering, Servier, Symarc, Teva, and Wyeth.
Rights and permissions
About this article
Cite this article
Felsenberg, D. Osteonecrosis of the jaw—a potential adverse effect of bisphosphonate treatment. Nat Rev Endocrinol 2, 662–663 (2006). https://doi.org/10.1038/ncpendmet0348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0348